IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 39 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2013. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Callan Capital, LLC | 70,000 | $180,000 | 0.09% |
Ifrah Financial Services, Inc. | 28,500 | $73,000 | 0.04% |
CHELSEA COUNSEL CO | 28,000 | $72,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,000 | $450,000 | 0.02% |
Highlander Capital Management, LLC | 5,000 | $12,850,000 | 0.01% |
GROUP ONE TRADING, L.P. | 154,815 | $398,000 | 0.01% |
Gerstein Fisher | 10,000 | $26,000 | 0.01% |
First Allied Advisory Services, Inc. | 40,000 | $103,000 | 0.01% |
Wellington Shields Capital Management, LLC | 10,000 | $26,000 | 0.01% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 123,857 | $318,000 | 0.00% |